Clinical Trial Update: A Study of SKB518 in Patients With Lung Cancer [Phase 2]

View source ↗

Summary

An ongoing phase 2 study evaluating SKB518 in patients with lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• SKB518 (SKB518)

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Lung Carcinoma | Phase 2 | Status: RECRUITING